cancers-logo

Journal Browser

Journal Browser

Conferences

24 October 2022, Online
Cancers Webinar | Plasma Oncology

Cold atmospheric plasma (CAP), also called non-thermal plasma (NTP), is a partially ionized gas that is being studied as a localized cancer therapy, in a field now coined as ‘plasma oncology’. CAP is created by applying electricity to a gas at atmospheric pressure and near room temperature and consists of neutral gas molecules, radicals, and excited species, which can rapidly react with cancerous tissue and induce therapeutic effects. These include the modulation and activation of multiple signaling pathways in cancer cells and the stimulation of host, anti-cancer immunity. Over the past decade, there is mounting evidence of the therapeutic, anti-cancer potential of CAP based on preclinical investigations: 2D and 3D in vitro studies, in silico computer modeling, and in vivo models. Now, the major challenge for the plasma oncology field is to take fundamental insights and translate this technology for clinical applications.

Webinar organized by 

  • Dr. Angela Privat-Maldonado, Research Group PLASMANT, Department of Chemistry, and Center for Oncological Research (CORE), University of Antwerp, Wilrijk-Antwerp, Belgium
  • Dr. Abraham Lin, Research Group PLASMANT, Department of Chemistry, and Center for Oncological Research (CORE), University of Antwerp, Wilrijk-Antwerp, Belgium
  • Prof. Dr. Annemie Bogaerts, Research Group PLASMANT, Department of Chemistry, University of Antwerp, Wilrijk-Antwerp, Belgium

The following experts will be present and talk:

  • Dr. Vandana Miller, Department of Microbiology and Immunology, Institute of Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA, USA

    Presentation Topic: Clinical considerations for plasma therapy for cancer

  • Dr. Audrey Glory, Institut du Cancer de Montréal (ICM), Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada

    Presentation Topic: Phase I clinical study with plasma therapy

  • Dr. Sander Bekeschus, ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Greifswald, Germany

    Presentation Topic: Cell death signaling and immune responses with anti-cancer cold physical plasma therapy

When? 24 October 2022 at 3:00pm CEST | 9:00am EDT | 9:00pm CST Asia

Register here for free!

Interested in contributing to the topic? You can find the Special Issue(s) linked to this topic and open for submission by clicking here.

https://cancers-8.sciforum.net

Back to TopTop